- ICH GCP
- US Clinical Trials Registry
- Researchers
- Japan
- Churg-Strauss Syndrome
Medical specialists from Japan tagged as investigators in clinical trials studying Churg-Strauss Syndrome
Total 18 results
-
Eri MusoSeen in:
- Osaka, Kitano Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Hidehiro YamadaSeen in:
- Kanagawa, St. Marianna University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Hiroaki DobashiSeen in:
- Kagawa, Kagawa University Hospital
- Kita-gun, Kagawa University Hospital - Dept of Immunology/ Rheumatology
Trials:- NCT05540327 (Principal Investigator)
- NCT01066208 (Principal Investigator)
- NCT05162586 (Principal Investigator)
-
Hirofumi MakinoSeen in:
- Okayama, Okayama University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Junichi HirahashiSeen in:
- Tokyo, University Tokyo Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Kazuo MatsuiSeen in:
- Chiba prefecture, Kamogawa City, Kameda Medical Centre, Kamogawa
Trials:- NCT01066208 (Principal Investigator)
-
Kazuo SuzukiSeen in:
- Chiba, Chiba University
Trials:- NCT01066208 (Principal Investigator)
-
Kiyoshi SekiyaSeen in:
- Kanagawa, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Koichi AmanoSeen in:
- Saitama Prefecture, Kawagoe, Saitama Medical University
- Saitama, GSK Investigational Site
Trials:- NCT01066208 (Principal Investigator)
- NCT05263934 (Principal Investigator)
-
Kunihiro YamagataSeen in:
- Ibaraki Prefecture, Tsukuba, Tsukuba University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Masami TaniguchiSeen in:
- Kanagawa, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Shigeto KobayashiSeen in:
- Saitama, Juntendo University Koshigaya Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Shouichi FujimotoSeen in:
- Miyazaki Prefecture, Miyazaki City, Miyazaki University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Takashi WadaSeen in:
- Kanazawa, Kanazawa University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Tomoaki HiguchiSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions: -
Wako YumuraSeen in:
- Tochigi-ken, Jichi Medical University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Yoshihiro ArimuraSeen in:
- Tokyo Prefecture, Mitaka, Kyorin University Hospital
Trials:- NCT01066208 (Principal Investigator)
-
Yoshinori KomagataSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT05263934 (Principal Investigator)
Conditions:
Clinical Trials on Churg-Strauss Syndrome
-
Brigham and Women's HospitalGlaxoSmithKlineCompletedChurg Strauss SyndromeUnited States
-
University Hospital Schleswig-HolsteinGlaxoSmithKlineCompletedChurg Strauss SyndromeGermany
-
University of PennsylvaniaUniversity of South Florida; University of OxfordCompletedVasculitis | Churg-Strauss Syndrome (CSS) | Microscopic Polyangiitis (MPA) | Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) | Granulomatosis With Polyangiitis (Wegener's) (GPA) | Wegener Granulomatosis (WG) | ANCA-Associated Vasculitis (AAV)United States
-
Hospices Civils de LyonUnknownChurg-Strauss SyndromeSwitzerland
-
GlaxoSmithKlineActive, not recruiting
-
Mounzer AghaTerminated
-
Fernando FervenzaGenentech, Inc.; Biogen; National Center for Research Resources (NCRR)Terminated
-
University of OxfordAmerican College of Rheumatology; The European League Against Rheumatism (EULAR) and other collaboratorsUnknownGiant Cell Arteritis | Wegener's Granulomatosis | Microscopic Polyangiitis | Polyarteritis Nodosa | Takayasu Arteritis | Churg Strauss SyndromeKorea, Republic of, United States, Germany, Australia, Japan, Ireland, Belgium, Italy, Denmark, Slovenia, Switzerland, Canada, Argentina, Austria, China, Czech Republic, Egypt, Finland, France, Hungary, India, Mexico, Netherlands, New... and more
-
Children's Hospital Medical Center, CincinnatiCompletedEosinophilic Gastroenteritis | Eosinophilic Esophagitis | Churg-Strauss Syndrome | Hypereosinophilic SyndromesUnited States
-
AstraZenecaActive, not recruitingEosinophilic Granulomatous VasculitisUnited States, Canada, France, Italy, Israel, United Kingdom, Japan, Germany, Belgium